TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma

J Thorac Oncol. 2020 Mar;15(3):e37-e39. doi: 10.1016/j.jtho.2019.10.020.

Authors

Weijun Mao¹, Ruo Chen¹, Junling Zhang², Mingfeng Zheng³

Affiliations

¹ Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
² Medical Department, 3D Medicines Inc., Shanghai, China.
³ Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China. Electronic address: m130208432@163.com.

PMID: 32093858
DOI: 10.1016/j.jtho.2019.10.020

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma of Lung / genetics
Anaplastic Lymphoma Kinase / genetics
Gene Fusion
Humans
Lung Neoplasms* / genetics
Oncogene Proteins, Fusion / genetics

Substances

Oncogene Proteins, Fusion
Anaplastic Lymphoma Kinase